Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics-Reference-Cited by-同舟云学术

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics

Published:2009-02-10 Issue:1 Volume:28 Page:76-82
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Penel Nicolas,Delord Jean-Pierre,Bonneterre Marie-Edith,Bachelot Thomas,Ray-Coquard Isabelle,Blay Jean-Yves,Pascal Laurent Benjamin,Borel Cécile,Filleron Thomas,Adenis Antoine,Bonneterre Jacques

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-009-9224-x.pdf

Reference34 articles.

1. Grunwald HW (2007) Ethical and design issues of phase 1 clinical trials in cancer patients. Cancer Invest 25:124–126 doi: 10.1080/07357900701225331

2. Kurzrock R, Benjamin RS (2005) Risks and benefits of phase 1 oncology trials, revisited. N Engl J Med 352:930–932 doi: 10.1056/NEJMe058007

3. Dillman RO, Koziol JA (1992) Phase I cancer trials: limitations and implications. Mol Biother 4:117–121 doi: 10.1007/BF02171756

4. Lipsett MB (1995) On the nature and ethics of phase I trials. J Clin Oncol 13:1049–1051

5. Roberts TG, Goulard BH, Squitieri L et al (2004) JW. Trends in the risk and benefits to patients with cancer participating in phase 1 clinical trial. JAMA 292:2130–2140 doi: 10.1001/jama.292.17.2130

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials;JAMA Network Open;2024-07-11

2. First-In-Human Phase 1 Clinical Trials – A Single-Center Experience In The Era Of Modern Oncotherapeutics;Scientific Reports;2020-05-13

3. Efficacy Considerations in Phase I Trials;Phase I Oncology Drug Development;2020

4. Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index;JNCI Cancer Spectrum;2019-09-19

5. Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials;Investigational New Drugs;2018-10-12